Hepatitis B Vaccine
Chemoprevention in gastrointestinal cancers is focus of review
Published in Vaccine Weekly, May 10th, 2006
According to the review from the United States, "Chemoprevention, pharmacological intervention for disease prevention, aims to intervene in pathways that lead to clinical disease before the disease occurs. Cancer chemoprevention is a relatively new field, but for gastrointestinal cancers, clinical trials have highlighted the chemopreventive potential of several agents. For colorectal neoplasia, trials with aspirin and other non-steroidal anti-inflammatory drugs (NSAIDS) and calcium have demonstrated the most significant reductions of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-10)
More Articles from Vaccine Weekly
- Ebola Virus Vaccine
cAdVax-based bivalent Ebola vaccine induces immunity against Sudan and Zaire Ebola species - HIV/AIDS Vaccine
Robust HIV-specific immune responses were induced by DNA vaccine plus vaccinia virus boost - Tuberculosis Vaccine
Mycobacterium bovis BCG expressing SIV Gag protein induces immune responses - Vaccinia Virus Vaccine
Vaccinia virus mutated in envelope proteins A33R and B5R are immunogenic - Virology
Chimeric SIN/VEE viruses clear Venezuelan equine encephalitis virus from brain - Allergy & Immunology
IgG binding plant N-glycans were generated in rabbits but not in mice - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
